Table 3 Reasons for the deviances and their percentage in the TUB for neurooncological tumors, head and neck tumors and sarcomas and musculoskeletal tumors
From: Cross-sectional increase of adherence to multidisciplinary tumor board decisions
Reasons for deviances | Neurooncological TUB (%) | Head and Neck TUB (%) | Sarcomas TUB (%) |
|---|---|---|---|
Patient wish | 33.5 | 45.5 | 14.3 |
Doctor decision | 22.0 | 26.8 | 25.0 |
Patient death | 34.1 | 17.1 | 17.9 |
Missing follow-up | 0.0 | 0.0 | 0.0 |
Treatment ex domo | 1.2 | 2.4 | 14.3 |
Missing documentation | 8.5 | 8.1 | 28.6 |
Outside the observed period | 0.0 | 0.0 | 0.0 |
Recommended drug not available | 0.6 | 0.0 | 0.0 |